Skip to main content

Royalty Pharma plc

RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001802768

In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 5 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.

13F holders, Q2 2026

Institutional positions in Royalty Pharma plc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
650
+64 vs. Q1 2026
Shares held
367.0M
+12.2M (+3.4%) vs. Q1 2026
Total value
$20.6B
+$3.57B (+21.0%) vs. Q1 2026
New holders
107
293 more added
Sold out
43
179 more reduced

8 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 650 institutions
Q1 2021: 216 institutionsQ2 2021: 238 institutionsQ3 2021: 234 institutionsQ4 2021: 267 institutionsQ1 2022: 280 institutionsQ2 2022: 286 institutionsQ3 2022: 320 institutionsQ4 2022: 338 institutionsQ1 2023: 338 institutionsQ2 2023: 327 institutionsQ3 2023: 315 institutionsQ4 2023: 364 institutionsQ1 2024: 381 institutionsQ2 2024: 380 institutionsQ3 2024: 396 institutionsQ4 2024: 417 institutionsQ1 2025: 447 institutionsQ2 2025: 458 institutionsQ3 2025: 490 institutionsQ4 2025: 542 institutionsQ1 2026: 594 institutionsQ2 2026: 650 institutions
Value heldQ2 2026: $20.6B
Q1 2021: $10.7BQ2 2021: $10.3BQ3 2021: $9.59BQ4 2021: $10.7BQ1 2022: $10.5BQ2 2022: $12.3BQ3 2022: $12.0BQ4 2022: $11.8BQ1 2023: $10.9BQ2 2023: $9.33BQ3 2023: $8.17BQ4 2023: $8.74BQ1 2024: $9.49BQ2 2024: $8.36BQ3 2024: $8.85BQ4 2024: $8.21BQ1 2025: $9.67BQ2 2025: $12.4BQ3 2025: $11.6BQ4 2025: $13.8BQ1 2026: $17.0BQ2 2026: $20.6B
Institutions holding RPRX and their total value by quarter
QuarterHoldersValue
Q2 2026650$20.6B
Q1 2026594$17.0B
Q4 2025542$13.8B
Q3 2025490$11.6B
Q2 2025458$12.4B
Q1 2025447$9.67B
Q4 2024417$8.21B
Q3 2024396$8.85B
Q2 2024380$8.36B
Q1 2024381$9.49B
Q4 2023364$8.74B
Q3 2023315$8.17B
Q2 2023327$9.33B
Q1 2023338$10.9B
Q4 2022338$11.8B
Q3 2022320$12.0B
Q2 2022286$12.3B
Q1 2022280$10.5B
Q4 2021267$10.7B
Q3 2021234$9.59B
Q2 2021238$10.3B
Q1 2021216$10.7B

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Royalty Pharma plc; share changes are against Q1 2026.

Institutions holding RPRX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Sunbelt Securities, Inc.––––Not filed